{
    "clinical_study": {
        "@rank": "33452", 
        "arm_group": [
            {
                "arm_group_label": "Group S", 
                "arm_group_type": "Active Comparator", 
                "description": "In group S, sevoflurane was initiated at %8 sevoflurane for anesthesia induction and maintained at 2% to %4 until the electrical stimulus was delivered, at which time it was turned off."
            }, 
            {
                "arm_group_label": "Group K", 
                "arm_group_type": "Active Comparator", 
                "description": "In group K, ketamine was given to 1mg/kg \u0131v bolus."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study was to evaluate the effect of sevoflurane or ketamine on the QTc and\n      Tp-e interval during in patients with major depression."
        }, 
        "brief_title": "Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Major Depression", 
            "Electroconvulsive Therapy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients enrolled in the study are randomly allocated by computer-generated random numbers\n      to receive either sevoflurane or ketamine for their initial ECT session. They subsequently\n      receive an alternative study drug in their next session, continuing to alternate between\n      drugs at each session until the sixth session.  In group S, sevoflurane are initiated at %8\n      sevoflurane for anesthesia induction and maintained at 2% to %4 until the electrical\n      stimulus is delivered, In group K, ketamine are given to 1mg/kg \u0131v bolus.\n\n      Electrical stimulus is delivered via bilateral frontotemporal electrodes.The mean arterial\n      pressure (MAP), HR, and ECG are recorded before anesthetic induction (T1), after anesthetic\n      induction (T2) and at 0, 1, 3, 10 min after the seizure ended (T3, T4, T5 and T6,\n      respectively).The QT interval and Tp-e interval are measured by one author, who was unaware\n      of group allocation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Unpremedicated\n\n          -  American Society of Anesthesiologists (ASA) I-II the patients\n\n          -  Major depressions patients scheduled for ECT sessions\n\n        Exclusion Criteria:\n\n          -  pregnant\n\n          -  with permanent pacemakers,\n\n          -  diabetes mellitus,\n\n          -  atrial fibrillation,\n\n          -  electrolyte imbalance,\n\n          -  patients taking antiarrhythmics and \u03b2-blockers."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01870219", 
            "org_study_id": "Turgut Ozal Medical Center"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group S", 
                "description": "sevoflurane was initiated at %8 sevoflurane for anesthesia induction and maintained at 2% to %4 until the electrical stimulus was delivered", 
                "intervention_name": "Sevoflurane", 
                "intervention_type": "Drug", 
                "other_name": "Volatile agent"
            }, 
            {
                "arm_group_label": "Group K", 
                "description": "ketamine was given to 1mg/kg \u0131v bolus", 
                "intervention_name": "Ketamine", 
                "intervention_type": "Drug", 
                "other_name": "Intravenous anesthetic agent"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Ketamine", 
                "Sevoflurane", 
                "Anesthetics, Intravenous"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "sevoflurane", 
            "ketamine", 
            "QT interval"
        ], 
        "lastchanged_date": "June 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Malatya", 
                    "country": "Turkey", 
                    "zip": "44315"
                }, 
                "name": "Turgut Ozal Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effects of Sevoflurane or Ketamine on QTc Interval During Electroconvulsive Therapy", 
        "overall_official": {
            "affiliation": "Associated Prof Dr", 
            "last_name": "Feray Erdil, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "ECG were recorded before anesthetic induction (T1), after anesthetic induction (T2) and at 0, 1, 3, 10 min after the seizure ended (T3, T4, T5 and T6, respectively)during ECT anesthesia with sevoflurane and ketamine.The QT interval was measured by one author, who was unaware of group allocation.", 
            "measure": "Evaluation Of QT interval", 
            "safety_issue": "Yes", 
            "time_frame": "10 minutes"
        }, 
        "reference": {
            "PMID": "19225403", 
            "citation": "Erdil F, Demirbilek S, Begec Z, Ozturk E, Ersoy MO. Effects of propofol or etomidate on QT interval during electroconvulsive therapy. J ECT. 2009 Sep;25(3):174-7. doi: 10.1097/YCT.0b013e3181903fa5."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01870219"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Inonu University", 
            "investigator_full_name": "Feray Erdil", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "ECG were recorded before anesthetic induction (T1), after anesthetic induction (T2) and at 0, 1, 3, 10 min after the seizure ended (T3, T4, T5 and T6, respectively)during ECT anesthesia with sevoflurane and ketamine.The Tp-e interval was measured by one author, who was unaware of group allocation.", 
                "measure": "Evaluation of Tp-e interval", 
                "safety_issue": "Yes", 
                "time_frame": "10 minutes"
            }, 
            {
                "description": "The duration of the EEG seizure was recorded from the EEG trace, and the peak heart rate (HR) during the convulsion was recorded from the ECG.", 
                "measure": "Seizure durations", 
                "safety_issue": "Yes", 
                "time_frame": "120 seconds"
            }
        ], 
        "source": "Inonu University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Inonu University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}